Paul Schimmel

Insider Reports History

Location
Cambridge, MA
Signature
Paul Schimmel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Schimmel:

Company Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Director Common Stock 1,413,023 $7,432,500 $5.26 09 Oct 2025 Indirect
aTYR PHARMA INC Director Common Stock 8,890 $46,761 $5.26 08 Oct 2025 Direct
aTYR PHARMA INC Director Stock Option (right to buy) 50,000 11 May 2026 Direct

Insider Reports Filed by Paul Schimmel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATYR aTYR PHARMA INC 11 May 2026 1 $0 4 Director 13 May 2026, 16:08
ATYR aTYR PHARMA INC 08 Oct 2025 2 +$911,801 4 Director 09 Oct 2025, 18:30
ATYR aTYR PHARMA INC 01 May 2025 1 $0 4 Director 02 May 2025, 17:23
ATYR aTYR PHARMA INC 22 Jul 2024 3 +$184,613 4 Director 24 Jul 2024, 17:29
ATYR aTYR PHARMA INC 22 May 2024 1 $0 4 Director 23 May 2024, 19:16
ATYR aTYR PHARMA INC 17 May 2023 1 $0 4 Director 19 May 2023, 16:32
ATYR aTYR PHARMA INC 10 May 2023 1 +$450,000 4 Director 11 May 2023, 09:00
ATYR aTYR PHARMA INC 26 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:54
ATYR aTYR PHARMA INC 26 Apr 2022 1 $0 4 Director 28 Apr 2022, 19:53
ATYR aTYR PHARMA INC 20 Sep 2021 3 +$2,000,000 4 Director 22 Sep 2021, 20:19
ATYR aTYR PHARMA INC 18 May 2021 1 +$199,000 4 Director 20 May 2021, 08:55
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .